All In MedTech

FDA Clearance Tracker · P250008-S001

Claire™ OCT System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 10, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P250008-S001
Device name
Claire™ OCT System
Applicant location
Toronto
Received
Mar 13, 2026
Decided
Aug 10, 2026
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P250008

Device type

Device class
Class III

Every decision under product code SHH

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at RBC Development, LLC (dba Vantage MedTech / RBC Medical Innovations), located at 17100 W 118th Terrace, Olathe, KS 66061, performing cart assembly, consumable (Specimen Immobilizer) assembly, receiving inspection, and tech services and laboratory functions at this facility.

Source documents

Other decisions for Perimeter Medical Imaging Ai, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.